My PCR
Create Account
Logo PCR

ACC Congress coverage: the interventional cardiology perspective

Stay up to date with the latest advances from American College of Cardiology Scientific Sessions, viewed through the lens of interventional cardiology.
Explore concise take-home messages, expert reviews, and exclusive interviews covering Hotline Sessions, Guidelines, and Late-Breaking Trials of key relevance to daily interventional practice.

Filter By

32 results

Coronary sinus reducer for the treatment of refractory angina: A randomised, placebo-controlled trial (ORBITA-COSMIC)

08 Apr 2024

Aaysha Cader interviews Rasha Al-Lamee and Michael Foley about the results of the ORBITA-COSMIC trial presented at ACC.24 in Atlanta.

Results showed that coronary sinus reducer relieved angina symptoms but lacked evidence of increased blood flow to the heart. While beneficial for refractory angina patients, its mechanism remains...

Rasha Al-Lamee

Author

Rasha Al-Lamee

Author

Aaysha Cader
Michael Foley

Author

Michael Foley
ORBITA-COSMIC: Coronary sinus reducer for the treatment of refractory angina

Protein and exercise to reverse frailty in older men and women undergoing transcatheter aortic valve replacement: The PERFORM-TAVR Trial

08 Apr 2024

Panos Xaplanteris provides his take on the results of PERFORM-TAVR presented by Jonathan Afilalo at ACC.24 in Atlanta.

Panagiotis Xaplanteris

Author

Panagiotis Xaplanteris
PERFORM-TAVR: Protein and exercise to reverse frailty in older patients undergoing TAVR